Faix D, Neese R, Kletke C, Wolden S, Cesar D, Coutlangus M, Shackleton C H, Hellerstein M K
Department of Nutritional Sciences, University of California, Berkeley 94720.
J Lipid Res. 1993 Dec;34(12):2063-75.
The mass isotopomer distribution analysis (MIDA) technique is applied here in men and menstruating women to quantify periodicities in the biosynthesis of serum cholesterol and very low density lipoprotein (VLDL)-palmitate. The isotopic enrichment of the true biosynthetic precursor (intracellular acetyl-CoA) during oral or intravenous administration of sodium[1-13C]- or [2-13C]acetate was calculated from mass isotopomer fractional abundances in free cholesterol and VLDL-palmitate, determined by gas chromatography-mass spectrometry (GC-MS). To convert fractional into absolute cholesterol synthesis rates, decay rate constants of plasma cholesterol were determined from the die-away curves of endogenously labeled high-mass isotopomers. Oral [13C]acetate was a 3-4 times more efficient means of labeling the precursor pool for VLDL-palmitate than was intravenous [13C]acetate, consistent with a splanchnic site of VLDL-fatty acid synthesis, whereas the precursor for free cholesterol had an intermediate enrichment, suggesting a contribution from extra-splanchnic tissues as well. Endogenous synthesis of serum cholesterol was 8-11 mg/kg per day (an estimated 65-75% of input into serum cholesterol); it was 1.5- to 3-fold higher at night than during the day (37-49 mg/h at night compared to 9-23 mg/h during the day) and did not vary over the menstrual cycle (608-697 mg/day). In contrast, endogenous synthesis of fatty acids made a relatively minor contribution to body fat pools (1/10-1/20) of input into VLDL-palmitate) compared to dietary fat intake; it was greater in the day-time, and was influenced by menstrual cycle (3-fold elevated in the follicular phase compared to the luteal phase), and body composition (higher in obese men than normal weight men, r2 = 0.59 for lipogenesis vs. body mass index). Factors responsible for periodicities in endogenous lipid synthesis can be studied in humans using this approach.
在此,我们将质量同位素异构体分布分析(MIDA)技术应用于男性和处于月经期的女性,以量化血清胆固醇和极低密度脂蛋白(VLDL)-棕榈酸酯生物合成中的周期性变化。通过气相色谱-质谱联用(GC-MS)测定游离胆固醇和VLDL-棕榈酸酯中的质量同位素异构体相对丰度,计算口服或静脉注射[1-13C]-或[2-13C]乙酸钠期间真正生物合成前体(细胞内乙酰辅酶A)的同位素富集情况。为了将相对丰度转换为绝对胆固醇合成速率,根据内源性标记的高质量同位素异构体的衰减曲线确定血浆胆固醇的衰减速率常数。口服[13C]乙酸钠标记VLDL-棕榈酸酯前体池的效率比静脉注射[13C]乙酸钠高3至4倍,这与VLDL脂肪酸合成的内脏部位一致,而游离胆固醇的前体具有中等程度的富集,表明也有来自内脏外组织的贡献。血清胆固醇的内源性合成量为每天8至11毫克/千克(估计占血清胆固醇输入量的65%至75%);夜间比白天高1.5至3倍(夜间为37至49毫克/小时,白天为9至23毫克/小时),且在月经周期中无变化(608至697毫克/天)。相比之下,与膳食脂肪摄入量相比,脂肪酸的内源性合成对VLDL-棕榈酸酯输入的体脂池贡献相对较小(1/10至1/20);白天合成量更大,且受月经周期影响(卵泡期比黄体期高3倍),还受身体组成影响(肥胖男性比正常体重男性更高,脂肪生成与体重指数的r2 = 0.59)。利用这种方法可以在人体中研究内源性脂质合成周期性变化的影响因素。